Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

NCT03932071 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Lung Metastases
Tumor Necrosis

Interventions

DRUG: Zoledronic Acid

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University